Researcher
Rein Verbeke
- Disciplines:Medicinal products, Pharmacognosy and phytochemistry, Pharmaceutics, Biomarker discovery and evaluation, Other pharmaceutical sciences, Drug discovery and development, Toxicology and toxinology, Pharmacotherapy, Pharmacology
Affiliations
- Department of Pharmaceutics (Department)
Member
From16 Sep 2013 → Today
Projects
1 - 3 of 3
- Exploration of an mRNA based nanovaccine platform and immunopeptidomics for the development of more effective tuberculosis vaccines.From1 Nov 2022 → TodayFunding: FWO fellowships
- Understanding and modulating the pro-inflammatory activity of lipid nanoparticles (LNP) in the COVID-19 mRNA vaccines: towards the development of more effective LNP formulations.From1 Oct 2022 → TodayFunding: FWO senior postdoctoral fellowship
- mRNA Lipid nanoparticles co-loaded with alpha-Galactosylceramide as a universal influenza vaccine platformFrom1 Oct 2020 → 30 Sep 2022Funding: BOF - postdoctoral mandates
Publications
1 - 10 of 21
- Fluorine MR imaging probes dynamic migratory profiles of perfluorocarbon-loaded dendritic cells after streptozotocin-induced inflammation(2022)
Authors: Shweta Saini, An-Sofie Vanherwegen, Sayuan Liang, Rein Verbeke, Hannelie Korf, Sabine Lentacker, Stefaan De Smedt, Conny Gysemans, Uwe Himmelreich
Pages: 321 - 332 - The dawn of mRNA vaccines : the COVID-19 case(2021)
Authors: Rein Verbeke, Sabine Lentacker, Stefaan De Smedt, Heleen Dewitte
Pages: 511 - 520 - Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across(2021)
Authors: An-Katrien Minnaert, Helena Vanluchene, Rein Verbeke, Sabine Lentacker, Stefaan De Smedt, Koen Raemdonck, Niek Sanders, Katrien Remaut
- mRNA-lipid nanoparticle COVID-19 vaccines : structure and stability(2021)
Authors: Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke, Gideon Kersten, Wim Jiskoot, Daan J. A. Crommelin
- Covipendium : information available to support the development of medical countermeasures and interventions against COVID-19(2021)
Authors: Martine Denis, Valerie Vandeweerd, Rein Verbeke, Anne Laudisoit, Tristan Reid, Emma Hobbs, Laure Wynants, Diane Van der Vliet
Pages: 1 - 296 - mRNA in cancer immunotherapy : beyond a source of antigen(2021)
Authors: Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Sabine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint
- Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation(2020)
Authors: Laurens Raes, Stephan Stremersch, Juan Carlos Fraire, Toon Brans, Glenn Goetgeluk, Stijn De Munter, Lien Van Hoecke, Rein Verbeke, Jelter Van Hoeck, Ranhua Xiong, et al.
- mRNA encoding a bispecific single domain antibody construct protects against influenza A virus infection in mice(2020)
Authors: Lien Van Hoecke, Rein Verbeke, Dorien De Vlieger, Heleen Dewitte, Kenny Roose, Sharon Van Nevel, Olga Krysko, Claus Bachert, Bert Schepens, Sabine Lentacker, et al.
Pages: 777 - 787 - Three decades of messenger RNA vaccine development(2019)
Authors: Rein Verbeke, Sabine Lentacker, Stefaan De Smedt, Heleen Dewitte
- Broadening the message : a nanovaccine co-loaded with messenger RNA and U+03B1-GalCer induces antitumor immunity through conventional and natural killer T cells(2019)
Authors: Rein Verbeke, Sabine Lentacker, Karine Breckpot, Jonas Janssens, Serge Van Calenbergh, Stefaan De Smedt, Heleen Dewitte
Pages: 1655 - 1669